Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
E. Borodulina, E. Skvortsova, E. Borodulina (Samara, Russian Federation). The death analysis of HIV-infected patients in the antituberculous hospital. Eur Respir J 2014; 44: Suppl. 58, 2607

Member's Comments

No comment yet.

Related content which might interest you: Treatment outcomes among multidrug-resistant tuberculosis (MDR-TB) cases at a referral hospital of infectious diseases in Italy Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016 MDR-TB treatment outcomes in HIV positive patients Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 Frequency of rifampicin resistance in re-treatment cases of pulmonary tuberculosis using Gene-Xpert in a tertiary care hospital tuberculosis clinic Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Study of prevalence of drug resistance in tuberculosis (TB) patients attending a tertiary care hospital at Mumbai Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016 Sputum culture conversion among the first cohorts of MDR-TB patients managed in Nigeria at a tertiary care hospital Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014 Molecular epidemiological analysis of cases of pulmonary tuberculosis in patients with multiple admissions to TB hospital Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease Year: 2016 The feature of BCG complications in children Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013 Time to sputum culture conversion as a prognostic marker for end-of-treatment outcome in the first cohorts of MDR-TB patients managed in a Nigerian tertiary hospital Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016 A comparison of drug sensitivity pattern in category-I failure versus category-I relapse pulmonary TB patients attending a tertiary care hospital in South Punjab, Pakistan. Is WHO category-II ATT regimen appropriate? Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Gene-Xpert for rapid detection of MDR-TB in re-treatment cases;a comparison with standard culture and DST Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Pattern of second line drug-resistance in MDR-TB treatment failure cases at a tertiary care tuberculosis treatment centre in western region of India Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016 Changing prevalence of MDR TB and XDR TB in a tertiary care hospital in India Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I Year: 2013 Experience of using diaskintest in adult patients with tuberculosis and non-tuberculosis respiratory diseases in a regional TB hospital Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Implementation of rapid drug-susceptibility testing for patients at high risk of multidrug-resistant tuberculosis in Cambodia Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 MOTT as a cause of treatment failure in pulmonary tuberculosis Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management Year: 2013 Restarting biologic agents in rheumatology patients who developed tuberculosis under TNFα-inhibitor treatment Source: International Congress 2015 – Latent TB infection and screening Year: 2015 Extrapulmonary tuberculosis in HIV infected patients admitted to the hospital Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA) Year: 2016 Patients over 35 years experience more side-effects during latent TB treatment: Experience from an urban hospital with a high incidence of Tuberculosis Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Clinical experience of clofazimine in the treatment of MDR-TB Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013